NDC 0078-1014

MAYZENT

Siponimod

MAYZENT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Siponimod.

Product ID0078-1014_7bc3f410-9309-4045-8eab-2dc16c0173fd
NDC0078-1014
Product TypeHuman Prescription Drug
Proprietary NameMAYZENT
Generic NameSiponimod
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-03-26
Marketing CategoryNDA /
Application NumberNDA209884
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameSIPONIMOD
Active Ingredient Strength1 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0078-1014-15

30 TABLET, FILM COATED in 1 BOTTLE (0078-1014-15)
Marketing Start Date2022-03-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "MAYZENT" or generic name "Siponimod"

NDCBrand NameGeneric Name
0078-0979MAYZENTsiponimod
0078-0986MAYZENTsiponimod
0078-1014MAYZENTsiponimod

Trademark Results [MAYZENT]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MAYZENT
MAYZENT
87816240 5846370 Live/Registered
Novartis AG
2018-03-01
MAYZENT
MAYZENT
79261592 not registered Live/Pending
NOVARTIS AG
2019-05-03
MAYZENT
MAYZENT
79156316 4714545 Live/Registered
Novartis AG
2014-09-12
MAYZENT
MAYZENT
79043338 3441076 Dead/Cancelled
Novartis AG
2007-08-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.